Pinjing Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pinjing Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jing Liao
Intensive Care Unit, The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
2 shared publications - Yongquan Zhang
Ruikang Hospital, Affiliated to Guangxi University of Traditional Chinese Medicine, Nanning, China
2 shared publications - Liyuan Mm Bei
Nephrology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
1 shared publication - Luoyi He
Ruikang Hospital, Affiliated to Guangxi University of Chinese Medicine, Nanning City, Guangxi, China
1 shared publication - Pengbing Nie
Ruikang Hospital, Affiliated to Guangxi University of Traditional Chinese Medicine, Nanning, China
1 shared publication - Zhanhong Tang
Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
1 shared publication
Latest Publications
- 15 March 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (7) , 9162-9169
DNA Methylation-Regulated ZDHHC13 Promotes the Progression of Parkinson’s Disease
Recent studies suggest that palmitoylation may influence proteins involved in neurotransmission and neurodegenerative changes, such as pathological α-synuclein. However, the role of palmitoylation in Parkinson’s disease (PD) has not been systematically investigated. Additionally, findings on DNA methylation changes and PD-associated gene expression remain inconsistent. This study aims to explore the causal relationship and mechanisms between palmitoylation genes, DNA methylation, and PD using Mendelian Randomization (MR). This study employed two-sample MR analysis, summary-data-based Mendelian Randomization (SMR) analysis, and mediation analysis, utilizing PD GWAS data from the Finngen database, palmitoylation genes data from the eQTLGen database, and DNA methylation data from the GoDMC database. First, a two-sample MR analysis was used to evaluate the causal relationship between the palmitoylation genes and PD. Then, the SMR method was applied to validate the association between gene expression and PD. Finally, mediation analysis was conducted to explore the mediating effect of DNA methylation on the relationship between expression of palmitoylation genes and PD. Our study found a significant positive correlation between high expression of the ZDHHC13 gene and increased PD risk. Each 1 standard deviation increase in ZDHHC13 expression was associated with a 24.20% increase in PD risk. Further DNA methylation analysis identified two key methylation sites (cg00161556 and cg27379915), which indirectly influenced the occurrence of PD by regulating the expression of the ZDHHC13 gene. Mediation effect analysis revealed that the methylation sites cg00161556 and cg27379915 indirectly promoted the development of PD by regulating the expression of the ZDHHC13 gene, with the mediation effect of ZDHHC13 gene expression accounting for 63.72% and 57.61% of the total effect, respectively. Sensitivity analysis and SMR analysis supported our findings, indicating high statistical robustness. This study highlights the role of DNA methylation in regulating ZDHHC13 during PD progression, suggesting potential clinical applications such as ZDHHC13 as a biomarker or therapeutic target for early PD diagnosis and treatment.
- 15 March 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (7) , 9162-9169
DNA Methylation-Regulated ZDHHC13 Promotes the Progression of Parkinson’s Disease
Recent studies suggest that palmitoylation may influence proteins involved in neurotransmission and neurodegenerative changes, such as pathological α-synuclein. However, the role of palmitoylation in Parkinson’s disease (PD) has not been systematically investigated. Additionally, findings on DNA methylation changes and PD-associated gene expression remain inconsistent. This study aims to explore the causal relationship and mechanisms between palmitoylation genes, DNA methylation, and PD using Mendelian Randomization (MR). This study employed two-sample MR analysis, summary-data-based Mendelian Randomization (SMR) analysis, and mediation analysis, utilizing PD GWAS data from the Finngen database, palmitoylation genes data from the eQTLGen database, and DNA methylation data from the GoDMC database. First, a two-sample MR analysis was used to evaluate the causal relationship between the palmitoylation genes and PD. Then, the SMR method was applied to validate the association between gene expression and PD. Finally, mediation analysis was conducted to explore the mediating effect of DNA methylation on the relationship between expression of palmitoylation genes and PD. Our study found a significant positive correlation between high expression of the ZDHHC13 gene and increased PD risk. Each 1 standard deviation increase in ZDHHC13 expression was associated with a 24.20% increase in PD risk. Further DNA methylation analysis identified two key methylation sites (cg00161556 and cg27379915), which indirectly influenced the occurrence of PD by regulating the expression of the ZDHHC13 gene. Mediation effect analysis revealed that the methylation sites cg00161556 and cg27379915 indirectly promoted the development of PD by regulating the expression of the ZDHHC13 gene, with the mediation effect of ZDHHC13 gene expression accounting for 63.72% and 57.61% of the total effect, respectively. Sensitivity analysis and SMR analysis supported our findings, indicating high statistical robustness. This study highlights the role of DNA methylation in regulating ZDHHC13 during PD progression, suggesting potential clinical applications such as ZDHHC13 as a biomarker or therapeutic target for early PD diagnosis and treatment.
- 25 January 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (7) , 3117-3124
Causal relationships between peripheral immune cells and Alzheimer’s disease: a two-sample Mendelian randomization study
Objective Previous research suggests that peripheral immune cells may play a role in the development of Alzheimer's disease (AD). Our study aims to determine if the composition of peripheral immune cells directly contributes to the occurrence of AD. Methods We utilized a two-sample Mendelian randomization (MR) approach to examine the association between peripheral immune cells and AD.The primary analysis method used was the inverse variance weighted (IVW) method, and we also conducted analyses using MR Egger, weighted median, simple mode, and weighted mode methods to ensure the accuracy of the results.Heterogeneity and horizontal pleiotropy were evaluated using Cochran's Q statistics and the MR Egger intercept, respectively. Results The study found a significant correlation between increased IgD + CD24- AC cells (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.01–1.06, P = 0.0172), increased CD4 + %leukocyte (OR = 1.08, 95% CI = 1.02–1.14, P = 0.0086), and increased CD4 + CD8dim AC cells (OR = 1.06, 95% CI = 1.01–1.11, P = 0.0218), with an increased susceptibility to AD. Conversely, an increase in EM DN (CD4-CD8-) %T cells (OR = 0.95, 95% CI = 0.92–0.99, P = 0.0164) and an increase in DN (CD4-CD8-) AC cells (OR = 0.93, 95% CI = 0.88–0.99, P = 0.0145) were associated with a protective effect against AD. Conclusion Our findings establish a causal link between peripheral immune cells and AD. This study is the first to examine the relationship between peripheral immune cells and AD using MR, offering valuable insights for early diagnosis and treatment decisions.
- 25 January 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (7) , 3117-3124
Causal relationships between peripheral immune cells and Alzheimer’s disease: a two-sample Mendelian randomization study
Objective Previous research suggests that peripheral immune cells may play a role in the development of Alzheimer's disease (AD). Our study aims to determine if the composition of peripheral immune cells directly contributes to the occurrence of AD. Methods We utilized a two-sample Mendelian randomization (MR) approach to examine the association between peripheral immune cells and AD.The primary analysis method used was the inverse variance weighted (IVW) method, and we also conducted analyses using MR Egger, weighted median, simple mode, and weighted mode methods to ensure the accuracy of the results.Heterogeneity and horizontal pleiotropy were evaluated using Cochran's Q statistics and the MR Egger intercept, respectively. Results The study found a significant correlation between increased IgD + CD24- AC cells (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.01–1.06, P = 0.0172), increased CD4 + %leukocyte (OR = 1.08, 95% CI = 1.02–1.14, P = 0.0086), and increased CD4 + CD8dim AC cells (OR = 1.06, 95% CI = 1.01–1.11, P = 0.0218), with an increased susceptibility to AD. Conversely, an increase in EM DN (CD4-CD8-) %T cells (OR = 0.95, 95% CI = 0.92–0.99, P = 0.0164) and an increase in DN (CD4-CD8-) AC cells (OR = 0.93, 95% CI = 0.88–0.99, P = 0.0145) were associated with a protective effect against AD. Conclusion Our findings establish a causal link between peripheral immune cells and AD. This study is the first to examine the relationship between peripheral immune cells and AD using MR, offering valuable insights for early diagnosis and treatment decisions.